M&A Deal Summary |
|
---|---|
Date | 2011-01-05 |
Target | Beijing Skywing Technology |
Sector | Medical Products |
Buyer(s) | Merck |
Deal Type | Add-on Acquisition |
Deal Value | 120M CNY |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1668 |
Sector | Diversified |
Employees | 64,011 |
Revenue | 21.0B EUR (2023) |
Merck is a science and technology company in healthcare, life science, and performance materials. Merck develops technologies that improve and enhance life from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.
DEAL STATS | # |
---|---|
Overall | 5 of 24 |
Sector (Medical Products) | 1 of 3 |
Type (Add-on Acquisition) | 4 of 20 |
Country (China) | 2 of 2 |
Year (2011) | 1 of 4 |
Size (of disclosed) | 8 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-12-20 |
EMD/Merck Crop BioScience
Brookfield, Wisconsin, United States EMD/Merck Crop BioScience, Inc. is a pharmaceutical company. EMD/Merck Crop BioScience is headquartered in Brookfield, Wiscosin. |
Sell | $275M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-03-22 |
Biotest - Microbiology Business
Germany Biotest - Microbiology Business manufactures and markets reagents, devices, and systems used in hygiene monitoring for air, surface, and manufacturing processes, as well as procedures to test end products for potential microorganism contamination. |
Buy | - |